<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 15 Jun 2026 06:51:58 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)</title>
   <link>http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Brainsway+%28BWAY%29/26643987.html</link>
   <description>&lt;p&gt;H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $17.00 price target on Brainsway (NASDAQ: BWAY).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;It has been widely reported that Valor Equity Partners, helmed by longtime Elon Musk confidant Antonio Gracias and founded in 2002, is currently one of the most significant institutional beneficiaries of the recently completed SpaceX (SPCX; not rated) IPO, holding a 6.7% stake that is valued at well over $100B following the latest trading activity in SpaceX stock. Valor Equity Partners first invested in SpaceX in 2008 and Antonio Gracias joined the SpaceX Board of Directors in 2010. We note that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Brainsway+%28BWAY%29/26643987.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	  </item>
  <item>
   <title>BrainsWay reports sustained benefits from accelerated depression treatment</title>
   <link>http://www.streetinsider.com/Corporate+News/BrainsWay+reports+sustained+benefits+from+accelerated+depression+treatment/26620277.html</link>
   <description>&lt;p&gt;BrainsWay Ltd. (NASDAQ: BWAY) presented 12-month durability data for its SWIFT accelerated Deep Transcranial Magnetic Stimulation protocol at the Clinical TMS Society Annual Meeting held June 4-6, 2026.&lt;/p&gt;&lt;p&gt;The study followed 65 patients who participated in BrainsWay's original FDA pivotal trial comparing the SWIFT protocol with standard Deep TMS treatment for Major Depressive Disorder. The SWIFT protocol reduces acute phase clinic visits by 70% compared to traditional treatment schedules.&lt;/p&gt;&lt;p&gt;According to the data presented by Colleen Hanlon, BrainsWay's Vice President of Medical Affairs, over 80% of SWIFT-treated patients remained in remission through the 12-month follow-up period based on clinician assessments. The percentage</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/BrainsWay+reports+sustained+benefits+from+accelerated+depression+treatment/26620277.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	  </item>
  <item>
   <title>BrainsWay reports sustained benefits from accelerated depression treatment</title>
   <link>http://www.streetinsider.com/FDA/BrainsWay+reports+sustained+benefits+from+accelerated+depression+treatment/26620277.html</link>
   <description>&lt;p&gt;BrainsWay Ltd. (NASDAQ: BWAY) presented 12-month durability data for its SWIFT accelerated Deep Transcranial Magnetic Stimulation protocol at the Clinical TMS Society Annual Meeting held June 4-6, 2026.&lt;/p&gt;&lt;p&gt;The study followed 65 patients who participated in BrainsWay's original FDA pivotal trial comparing the SWIFT protocol with standard Deep TMS treatment for Major Depressive Disorder. The SWIFT protocol reduces acute phase clinic visits by 70% compared to traditional treatment schedules.&lt;/p&gt;&lt;p&gt;According to the data presented by Colleen Hanlon, BrainsWay's Vice President of Medical Affairs, over 80% of SWIFT-treated patients remained in remission through the 12-month follow-up period based on clinician assessments. The percentage</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/BrainsWay+reports+sustained+benefits+from+accelerated+depression+treatment/26620277.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;BURLINGTON, Mass. and JERUSALEM, June  09, 2026  (GLOBE NEWSWIRE) -- BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD).&lt;/p&gt;  &lt;p&gt;The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite, randomized, controlled</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/BrainsWay+Presents+First+SWIFT%E2%84%A2+Accelerated+Deep+TMS+12-Month+Durability+Data+at+Clinical+TMS+Society+Annual+Meeting/26620256.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  6-K        Brainsway Ltd.            For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26620270.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  6-K        Brainsway Ltd.            For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26620270.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  6-K        Brainsway Ltd.            For: Jun 09</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26620270.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+09/26620270.html</guid>
   <pubDate>Tue, 09 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: Jun 01  Filed by: Roth Yiftach</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26598681.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</guid>
   <pubDate>Wed, 03 Jun 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: Jun 01  Filed by: Roth Yiftach</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26598681.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</guid>
   <pubDate>Wed, 03 Jun 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: Jun 01  Filed by: Roth Yiftach</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26598681.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+Jun+01++Filed+by%3A+Roth+Yiftach/26598681.html</guid>
   <pubDate>Wed, 03 Jun 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Brainsway Ltd.                         Filed by: MEITAV INVESTMENT HOUSE LTD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26595273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</guid>
   <pubDate>Wed, 03 Jun 2026 07:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Brainsway Ltd.                         Filed by: MEITAV INVESTMENT HOUSE LTD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26595273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</guid>
   <pubDate>Wed, 03 Jun 2026 07:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Brainsway Ltd.                         Filed by: MEITAV INVESTMENT HOUSE LTD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</link>
   <description>si-local-file:///var/storage/secattach/20260603/26595273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Brainsway+Ltd.+++++++++++++++++++++++++Filed+by%3A+MEITAV+INVESTMENT+HOUSE+LTD/26595273.html</guid>
   <pubDate>Wed, 03 Jun 2026 07:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: May 25  Filed by: Mitrany Rayten Michal Ety</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549744.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</guid>
   <pubDate>Tue, 26 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: May 25  Filed by: Mitrany Rayten Michal Ety</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549744.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</guid>
   <pubDate>Tue, 26 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: May 25  Filed by: Mitrany Rayten Michal Ety</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549744.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+25++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26549744.html</guid>
   <pubDate>Tue, 26 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Brainsway (BWAY) PT Raised to $17 at H.C. Wainwright</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2417+at+H.C.+Wainwright/26545553.html</link>
   <description>(Updated - May 26, 2026 6:52 AM EDT)

&lt;p&gt;H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Brainsway (NASDAQ: BWAY) to $17.00 (from $15.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Revenue in 1Q26 increased 35% vs. the year-ago period to $15.5M, solidly beating our forecast of only $13.9M. Remaining performance obligations (RPOs) increased to $75M as of March 31, 2026, up 25% compared to the prior year period. The company shipped a net total of 117 Deep TMS systems during 1Q26, representing a 44% increase vs. the year-ago period. Total installed base reached approximately 1,820 systems, up from only</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Brainsway+%28BWAY%29+PT+Raised+to+%2417+at+H.C.+Wainwright/26545553.html</guid>
   <pubDate>Tue, 26 May 2026 06:52:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	  </item>
  <item>
   <title>Brainsway (BWAY) PT Raised to $17 at H.C. Wainwright</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2417+at+H.C.+Wainwright/26545553.html</link>
   <description>(Updated - May 26, 2026 6:52 AM EDT)

&lt;p&gt;H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Brainsway (NASDAQ: BWAY) to $17.00 (from $15.00) while maintaining a Buy rating.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Revenue in 1Q26 increased 35% vs. the year-ago period to $15.5M, solidly beating our forecast of only $13.9M. Remaining performance obligations (RPOs) increased to $75M as of March 31, 2026, up 25% compared to the prior year period. The company shipped a net total of 117 Deep TMS systems during 1Q26, representing a 44% increase vs. the year-ago period. Total installed base reached approximately 1,820 systems, up from only</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Brainsway+%28BWAY%29+PT+Raised+to+%2417+at+H.C.+Wainwright/26545553.html</guid>
   <pubDate>Tue, 26 May 2026 06:52:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: May 19  Filed by: Mitrany Rayten Michal Ety</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+19++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26531010.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26531010.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+19++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26531010.html</guid>
   <pubDate>Thu, 21 May 2026 06:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
  <item>
   <title>Form  4          Brainsway Ltd.            For: May 19  Filed by: Mitrany Rayten Michal Ety</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+19++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26531010.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26531010.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Brainsway+Ltd.++++++++++++For%3A+May+19++Filed+by%3A+Mitrany+Rayten+Michal+Ety/26531010.html</guid>
   <pubDate>Thu, 21 May 2026 06:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BWAY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05892621</category>
   	  </item>
 </channel>
</rss>
